文献速递冠心病外科

血糖控制强度影响冠状动脉旁路移植术后长期生存

Intensity of Glycemic Control Affects Long-Term Survival After Coronary Artery Bypass Graft Surgery.
PubMed 文献 · Ann Thorac Surg · 2018-09-28

该研究基于区域登记数据,纳入2008至2015年间6415例接受体外循环孤立CABG且术前有HbA1c记录的患者,按HbA1c分为四组。调整患者风险因素后,HbA1c较高与院内死亡或并发症无关,但长期生存显著较差,HbA1c每升高一个单位死亡风险增加13%。

要点

  • 术前HbA1c较高与CABG术后长期生存较差独立相关。
  • HbA1c每升高一个单位,调整后死亡风险增加13%。
  • 调整风险后,HbA1c水平与院内死亡或并发症无显著关联。

核心结论

  • 术前HbA1c反映的血糖控制水平可预测CABG术后长期生存,水平越高预后越差。
  • 术后更好的血糖控制能否改变这一风险尚待确定。

研究设计与样本

  • 来自区域连续病例登记,纳入2008至2015年6415例接受体外循环孤立CABG且有术前HbA1c记录的患者。
  • 按HbA1c分为四组:低于5.7%(n=1713)、5.7%至6.4%(n=2505)、6.5%至8.0%(n=1377)、高于8%(n=820)。
  • 使用多变量逻辑回归和Cox模型调整患者及疾病风险因素。

主要发现

  • 研究包括3740例(58%)未诊断为糖尿病的患者和2674例糖尿病患者。
  • 非糖尿病患者中52%(n=1933)存在糖尿病前期(HbA1c 5.7%至6.4%)。
  • 较高的HbA1c值与较年轻年龄、女性、较高体重指数、更多合并症、较低射血分数、更多三支冠状动脉病变和近期心肌梗死相关(所有趋势p < 0.05)。
  • 调整患者风险后,较高的HbA1c值不与院内死亡或并发症发生率升高相关。
  • 长期生存随HbA1c升高显著变差,HbA1c每升高一个单位死亡风险增加13%(调整风险比1.13;95%置信区间1.07至1.19;p < 0.001)。

临床怎么用

  • 在心胸外科CABG术前评估中,应关注术前HbA1c水平以识别长期生存预后较差的高风险患者。
  • 对于HbA1c较高的患者,术后优化血糖控制是否改善长期生存尚需进一步研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A patient's hemoglobin (Hb) A1c level, regardless of diabetic status, is a measure of glycemic control. Studies have found it is an independent predictor of short-term death in patients undergoing coronary artery bypass grafting (CABG). In this study, we used preoperative HbA1c to assess whether levels are associated with short-term and long-term survival after CABG. METHODS: From a regional registry of consecutive cases, we identified 6,415 patients undergoing on-pump isolated CABG from 2008 to 2015 with documented preoperative HbA1c level. We defined four HbA1c groups: less than 5.7% (n = 1,713), 5.7% to 6.4% (n = 2,505), 6.5% to 8.0% (n = 1,377), and more than 8% (n = 820). Relationship to in-hospital outcomes and long-term survival was assessed. Outcome rates and hazard ratios were adjusted for patient and disease risk factors using multivariable logistic regression and Cox models. RESULTS: The study included 3,740 patients (58%) not diagnosed as having diabetes and 2,674 with diabetes. Prediabetes (HbA1c 5.7% to 6.4%) was documented in 52% (n = 1,933) of nondiabetic patients. Higher HbA1c values were associated with younger age, female sex, greater body mass index, more comorbid diseases, lower ejection fraction, more 3-vessel coronary disease, and recent myocardial infarction (p < 0.05 trend for all). After adjustment for patient risk, greater HbA1c values were not associated with higher rates of in-hospital death or morbidity. Long-term survival was significantly worse as HbA1c increased. Risk of death increased by 13% for every unit increase in HbA1c (adjusted hazard ratio, 1.13; 95% confidence interval, 1.07 to 1.19; p < 0.001). CONCLUSIONS: Preadmission glycemic control, as assessed by HbA1c, is predictive of long-term survival, with higher levels associated with poorer prognosis. Whether this risk can be modified by better glycemic control postoperatively remains to be determined.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Robich MP, Iribarne A, Leavitt BJ, et al. Intensity of Glycemic Control Affects Long-Term Survival After Coronary Artery Bypass Graft Surgery. Ann Thorac Surg. 2018. PMID: 30273572. doi:10.1016/j.athoracsur.2018.07.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。